Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutic preparation for treating viral myocarditis

A technology for viral myocarditis and drugs, applied in the directions of antiviral agents, drug combinations, and medical preparations containing active ingredients, etc., can solve the problems of patients evolving into dilated cardiomyopathy and poor results, and improve the treatment efficiency. , the effect of high safety

Inactive Publication Date: 2015-11-25
SHANDONG UNIV
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to the lack of targeted Western medicine specific therapy and individual differences in individual reactivity, some patients may evolve into dilated cardiomyopathy, resulting in serious consequences. Currently, immunosuppressants, interferon and cardiomyocyte nutrition agents are often used clinically. Symptomatic treatment and traditional Chinese medicine treatment, but the effect of long-term use is not good

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Embodiment 1: the preparation of the pharmaceutical preparation for the treatment of viral myocarditis

[0035] Recipe: Astragalus 30 grams, Ophiopogon japonicus 16 grams, red ginseng 16 grams, kudzu root 13 grams, apocynum leaves 13 grams, jujube kernels 22 grams, bamboo ginseng 18 grams, licorice 12 grams, jujube 7 grams, tiankui seeds 5 grams, perindopril 8 grams.

[0036] Preparation:

[0037] (1) Weigh astragalus, Radix Ophiopogon japonicus, red ginseng, kudzu root, apocynum leaf, jujube seed, ginseng, licorice, jujube, geranium seeds according to the formula, add water to decoct twice, filter (the first Add 8 times the amount of water for the first time and decoct for 2 hours; add 6 times the amount of water for the second time and decoct for 1.5 hours), combine the filtrates, concentrate to an extract with a relative density of 1.2 (50°C), and dry under reduced pressure at 80°C. Crush, pass through a 100-mesh sieve, and set aside;

[0038] (2) Mix perindopril ...

Embodiment 2

[0039] Embodiment 2: the preparation of the pharmaceutical preparation for the treatment of viral myocarditis

[0040] Recipe: Astragalus 25 grams, Ophiopogon japonicus 25 grams, red ginseng 12 grams, kudzu powder 15 grams, apocynum leaves 10 grams, jujube kernels 25 grams, bamboo ginseng 12 grams, licorice 12 grams, jujube 5 grams, tiankui seeds 6 grams, perindopril 5 grams.

[0041] The preparation method is the same as in Example 1.

Embodiment 3

[0042] Embodiment 3: the preparation of the pharmaceutical preparation for the treatment of viral myocarditis

[0043] Recipe: Astragalus 35 grams, Ophiopogon japonicus 12 grams, red ginseng 25 grams, kudzu powder 10 grams, apocynum leaves 15 grams, jujube seeds 20 grams, bamboo ginseng 25 grams, licorice 8 grams, jujube 10 grams, tiankui seeds 3 grams, perindopril 10 grams.

[0044] The preparation method is the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutic preparation for treating viral myocarditis. The pharmaceutic preparation is prepared from the following raw materials in parts by weight: 25-35 parts of astragalus membranaceus, 12-25 parts of radix ophiopogonis, 12-25 parts of red ginseng, 10-15 parts of pachyrhizua angulatus, 10-15 parts of folium apocyni veneti, 20-25 parts of spina date seeds, 12-25 parts of panax japonicus, 8-12 parts of licorice root, 5-10 parts of fructus choerospondiatis, 3-6 parts of muskroot-like semiaquilegia root, and 5-10 parts of perindopril. The invention further discloses a preparation method of the pharmaceutic preparation. According to the pharmaceutic preparation, the Chinese and western medicine components are mixed, so that the purpose of treating both symptoms and root causes of diseases is achieved, the treatment effect is good, and no toxic or side effect is generated.

Description

technical field [0001] The invention relates to a pharmaceutical preparation for treating viral myocarditis. Background technique [0002] Myocarditis refers to localized or diffuse acute or chronic inflammatory lesions of the myocardium, which can be divided into two types: infectious and non-infectious. Sincerely. The degeneration and necrosis of cardiomyocytes or interstitial inflammation caused by viruses is called viral myocarditis. About 90% of patients with myocarditis complain of arrhythmia as the main complaint or the first symptom. Symptoms such as palpitations, chest tightness, precordial pain, dizziness, and fatigue are common, and syncope or even A-Syndrome may occur. Severe diffuse myocarditis can cause acute cardiomyopathy. Failure, prone to cardiogenic shock or lead to cardiomyopathy. Due to the lack of targeted Western medicine specific therapy and individual differences in individual reactivity, some patients may evolve into dilated cardiomyopathy, resul...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8968A61P9/00A61P31/12A61K38/05
Inventor 孟晓慧张萍
Owner SHANDONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com